Shearman & Sterling represented the initial purchasers led by Deutsche Bank AG, London Branch, Deutsche Bank Aktiengesellschaft, HSBC Bank plc, J.P. Morgan Securities plc and Morgan Stanley & Co. International plc in connection with an offering of €850 million aggregate principal amount of 0.375 percent senior notes due 2026 and €850 million aggregate principal amount of 0.750 percent senior notes due 2030 by Reckitt Benckiser Treasury Services (Nederland) B.V. and of £500 million aggregate principal amount of 1.750 percent senior notes due 2032 by Reckitt Benckiser Treasury Services plc. The senior notes were guaranteed by Reckitt Benckiser Group plc (Reckitt Benckiser). The transaction closed on May 19, 2020.
Reckitt Benckiser is a global consumer goods leader in health, hygiene and nutrition and is in the top 10 of FTSE 100 companies. Today it is the global No. 1 or No. 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by over 20 global brands, including Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.
The Shearman & Sterling team below also includes associate Alex Liebman.